The Pennsylvania Opioid Data Dashboard provides data behind Pennsylvania's response to the opioid crisis.

The Wolf Administration is increasing access to treatment for people suffering with opioid use disorder. This tells the story of treatment within the state of Pennsylvania.

Governor's Goal - The opioid crisis is a public health emergency in Pennsylvania that is contributing to addiction, overdose emergencies, and deaths. The crisis is unprejudiced in its reach and devastation, impacting all areas of the state – including urban, suburban, and rural communities – and Pennsylvanians of all ages. However, Pennsylvania's experience shows that, with a proactive response, it is possible to prevent substance use disorders, increase access to treatment, and rescue those in dire need.

The Wolf Administration is helping to rescue opioid use disorder patients and children born suffering from withdrawal symptoms by enhancing the state's response to the opioid epidemic.

The Wolf Administration is working to reduce over-prescribing of opioids through use of the the Prescription Drug Monitoring Program and prescribing guidelines.

This page highlights the community impact of opioids on families and children, the economy, the, criminal justice system, and other opioid-related diseases (e.g., neonatal abstinence syndrome, hepatitis C, HIV).

This dataset contains summary information on overdose responses and naloxone administrations by Pennsylvania criminal justice agencies and some third-party (i.e. EMS, Fire, Medical Staff, etc) first responders voluntarily entering incident data. Due to the voluntary nature of the application, the ODIN information provided may not represent the totality of all overdose and/or naloxone administration incidents involving criminal justice agencies occurring within the Commonwealth. Although this dataset does include some third-party administrations of naloxone, it should not be used to measure overdose response and naloxone administration incidents among all first responders.

This page describes information on the impacts of opioids on families and children.

This page links users commonwealth and regional opioid resources and data

View quarterly trends in opioid dispensation data for all Schedule II-V opioids.
Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx
More information from U.S. Department of Justice
https://www.deadiversion.usdoj.gov/schedules/
Schedule I Controlled Substances
Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.
Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ("Ecstasy").
Schedule II/IIN Controlled Substances (2/2N)
Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence.
Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone.
Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®), methamphetamine (Desoxyn®), and methylphenidate (Ritalin®).
Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital.
Schedule III/IIIN Controlled Substances (3/3N)
Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.
Examples of Schedule III narcotics include: products containing not more than 90 milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine (Suboxone®).
Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®), phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone.
Schedule IV Controlled Substances
Substances in this schedule have a low potential for abuse relative to substances in Schedule III.
Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol (Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®), lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam (Halcion®).
Schedule V Controlled Substances
Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics.
Examples of Schedule V substances include: cough preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC®, Phenergan with Codeine®), and ezogabine.